Navigation Links
eResearchTechnology Names New Chief Financial Officer
Date:7/23/2008

PHILADELPHIA, July 23 /PRNewswire-FirstCall/ -- eResearchTechnology, Inc. (eRT or the Company), (Nasdaq: ERES), a leading provider of centralized ECG and eClinical technology, ePRO and other services to the pharmaceutical, biotechnology, medical device and related industries, announced today the appointment of Mr. Keith D. Schneck as Executive Vice President and Chief Financial Officer effective July 28th, 2008.

Mr. Schneck joins eRT with over 30 years of senior financial experience and executive management expertise in high growth companies and public accounting. He was previously Executive Vice President and Chief Financial Officer of Neoware, Inc., a publicly traded company before its acquisition in September 2007 by Hewlett-Packard, and he consulted in a transitional capacity until December 2007. Prior to Neoware, he served as Chief Financial Officer of T-Networks, a venture capital-funded start-up company that provides components to the telecommunications market. Mr. Schneck also has held positions as President and Chief Financial Officer for AM Communications and as Chief Operating Officer and Chief Financial Officer of Integrated Circuit Systems, also a publicly traded company. Mr. Schneck is a CPA with over 10 years of public accounting experience with KPMG LLP. During his career, Mr. Schneck has been responsible for a variety of financial and general management functions, including investor relations, finance, operations, business development, acquisitions and integration of acquired operations. He holds a BS from West Chester University and attended the Advanced Management Program at the Harvard Business School. In his position as Executive Vice President and Chief Financial Officer, Mr. Schneck will be responsible for financial reporting, corporate finance, investor relations and legal affairs for eRT.

"We are excited to have someone of Keith's expertise and talent join eRT," said Dr. Michael McKelvey, President and Chief Executive Officer of eRT. "His previous experience as a public company CFO and a Chief Operating Officer will be important as we continue to grow and implement our future strategy."

"I believe eRT is well positioned with a strong business model and a highly competent management team in an industry with attractive growth opportunities," commented Mr. Schneck. "I look forward to working with the team as we define and execute strategies that provide unique value to our customers, shareholders and employees."

About eResearchTechnology, Inc.

Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.eRT.com) is a provider of technology and services to the pharmaceutical, biotechnology and medical device industries on a global basis. The Company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The Company is also a leader in providing technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis, and distribution of clinical data in all phases of clinical development.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements, including, but not limited to, 2008 financial guidance, involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.


'/>"/>
SOURCE eResearchTechnology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. eResearchTechnology to Present at the FBR 12th Annual Spring Investor Conference on May 28th 2008
2. eResearchTechnology Announces Resignation of its CFO
3. eResearchTechnology Reports First Quarter 2008 Results
4. eResearchTechnology to Present at the Deutsche Bank 33rd Annual Healthcare Conference on May 7th 2008
5. eResearchTechnology, Inc. to Announce 2008 First Quarter Results on May 5, 2008
6. eResearchTechnology, Inc. and nSpire Health, Inc. Form Alliance to Deliver Integrated Cardiac Safety and Pulmonary Clinical Trial Services
7. eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results
8. eResearchTechnology, Inc. to Announce 2007 Fourth Quarter Results on February 26, 2008
9. eResearchTechnology to Present at the UBS Global Healthcare Services Conference 2008 on February 11th
10. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
11. HistoRx Names Bill Sullivan Senior Vice President, Diagnostic Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... ... April 28, 2016 , ... ... for Connecticut's innovative, growing companies, today announced the launch of VentureClash , ... (fintech) companies. , “VentureClash looks to attract the best early-stage companies ...
(Date:4/27/2016)... (PRWEB) , ... April 27, 2016 , ... Cambridge ... by semantic web technology, today announced that it has been named to The Silicon ... sciences, financial services and other markets, Cambridge Semantics serves the needs of end users ...
(Date:4/27/2016)... 27, 2016 NanoStruck Technologies ... NSKQB) ( Frankfurt : 8NSK) gibt ... vom 13. August 2015 die Genehmigung von der ... zusätzliche 200.000.000 Einheiten auf 400.000.000 Einheiten zu erhöhen, ... Davon wurden 157.900.000 Einheiten mit dem ersten Teil ...
(Date:4/27/2016)... ... April 27, 2016 , ... PathSensors, Inc., a leading ... Dr. Lamka will assist PathSensors in expanding the use of the company’s CANARY® ... CANARY® test platform for the detection of harmful pathogens, including a number of ...
Breaking Biology Technology:
(Date:4/19/2016)... UAE, April 20, 2016 The ... as a compact web-based "all-in-one" system solution for all ... fingerprint reader or the door interface with integration authorization ... access control systems. The minimal dimensions of the access ... into the building installations offer considerable freedom of design ...
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
Breaking Biology News(10 mins):